Malvern Panalytical and Concept Life Sciences Launch Amplify Analytics

Malvern Panalytical (Malvern, UK) and Concept Life Sciences (Cheshire, UK) have jointly launched Amplify Analytics - a new range of highly flexible services designed to help pharmaceutical companies rapidly identify those drug candidates that meet bioavailability and processability requirements, speeding and de-risking drug development.

Data-driven ‘win quick, fail fast’ approaches that reduce technical uncertainties in early-stage development are critical to a project’s longer-term success. With growing constraints on pharmaceutical laboratory resources and expertise, partnership is increasingly used to enable quick decisions on the best form of a molecule and the deployment of the right characterization strategies to achieve rapid downstream development and scale-up. Flexibility in the way in which partner services are delivered is one of the keys to making the best use of all available resources to deliver the right data, reduce risks in product development, and improve project return on investment.

Amplify Analytics brings together Malvern Panalytical’s physicochemical characterization expertise and Concept Life Sciences’ bespoke chemistry and analytical services, drawing on their collective understanding of the requirements for assessing drug developability and scale-up. The result is a range of uniquely scaleable services that deliver bespoke combinations of analytics, know-how, instrumentation and expert support to customers.

This extends from supplying access to specific analytical capabilities, or providing complete third-party management of an entire project, through to deploying techniques, training and data interpretation support at a customer site. Each element is designed in partnership with the customer to enable fast, reliable decision-making on the suitability of drug candidates for further development.

Dr Paul Kippax, Pharmaceutical & Food Sector Director at Malvern Panalytical, said: “Amplify Analytics combines Concept Life Sciences’ expertise in discovery chemistry, API screening and GMP manufacturing with Malvern Panalytical’s long-held knowledge and experience in applying physicochemical analysis to drug development.”

“Within the pharmaceutical industry, an increased emphasis on return on investment and the application of continuous and additive manufacturing methods is pushing the desire to find small molecule drug candidates which easily fit development and scale-up capabilities – this can be unlocked and enabled by the application of physicochemical screening during early development. The unique blend of insight and know-how offered by Amplify Analytics delivers the vision required to make the right decisions on key projects quickly and confidently.”

For further details, please visit malvernpanalytical.com/AmplifyAnalytics

Source: https://www.malvernpanalytical.com/en

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2020, September 26). Malvern Panalytical and Concept Life Sciences Launch Amplify Analytics. AZoM. Retrieved on October 20, 2020 from https://www.azom.com/news.aspx?newsID=54683.

  • MLA

    Malvern Panalytical. "Malvern Panalytical and Concept Life Sciences Launch Amplify Analytics". AZoM. 20 October 2020. <https://www.azom.com/news.aspx?newsID=54683>.

  • Chicago

    Malvern Panalytical. "Malvern Panalytical and Concept Life Sciences Launch Amplify Analytics". AZoM. https://www.azom.com/news.aspx?newsID=54683. (accessed October 20, 2020).

  • Harvard

    Malvern Panalytical. 2020. Malvern Panalytical and Concept Life Sciences Launch Amplify Analytics. AZoM, viewed 20 October 2020, https://www.azom.com/news.aspx?newsID=54683.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit